Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione reductase inhibitor bcnu

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS

Glutaredoxin Mediates Akt and eNOS Activation by Flow in a Glutathione Reductase Dependent Manner Arteriosclerosis, Thrombosis, and Vascular Biology The NAPstar family of NADP redox state sensors highlights glutathione as the primary mediator of anti oxidative electron flux bioRxiv RCSB PDB 1GRH: INHIBITION OF HUMAN GLUTATHIONE REDUCTASE BY THE NITROSOUREA DRUGS 1,3 BIS(2 CHLOROETHYL) 1 NITROSOUREA AND 1 (2 CHLOROETHYL) 3 (2 HYDROXYETHYL) 1 NITROSOUREA Effects of exercise and glutathione reductase inhibition (with BCNU) on Download Scientific Diagram Thiamine disulfide derivatives in thiol redox regulation: Role of thioredoxin and glutathione systems Folda 2025 BioFactors Wiley Online Library

SKU: 22958011066 · From metron-ms.com

4.4
USD28.77 USD51.77

Pay in 4 interest-free payments of $7.19 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Hao L, Mi J, Song L, Guo Y, Li Y, Yin Y, et al

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS

In this study, Zhou et al

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS

Perez-Castro, L

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS

Commonly Reported Research Observations Injection-site redness or irritation Temporary swelling or warmth sensation at the administration site Burning or stinging during administration Temporary skin sensitivity or irritation Mild headaches Temporary fatigue or tiredness Mild nausea Temporary itching or flushing sensations Temporary blue-tinted discoloration beneath the administration area in some research settings Copper-Related Research Considerations Because GHK-Cu is a copper-binding peptide, some research protocols may monitor for: Copper- and zinc-balance variability Increased sensitivity in higher-frequency protocols Temporary skin-related response variability Individual differences in antioxidant-response pathways Research involving prolonged or higher-frequency protocols commonly investigates the inclusion of: Zinc supplementation Vitamin C supplementation alongside GHK-Curelated research models

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS

Marketer details Name: Leeford Healthcare Ltd Address: 203, Mangalam, Kulupwadi, Borivali (E), Mumbai-400066 Vendor Details Country of origin: India 1165 MRP 1640.6329% off Save more with additional offers Get up to 75 cashback on a minimum order value (MOV) of 499 and above, valid once per customer

glutathione reductase inhibitor bcnu Carmustine (BCNU), DNA alkylating agent (CAS 154-93-8) Glutaredoxin Mediates Akt and eNOS
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products